These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25140793)

  • 1. Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.
    Moore RA; Sturdevant DE; Chesebro B; Priola SA
    J Proteome Res; 2014 Nov; 13(11):4620-34. PubMed ID: 25140793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
    Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
    PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of prion protein in the brain that is not associated with transmissible disease.
    Piccardo P; Manson JC; King D; Ghetti B; Barron RM
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4712-7. PubMed ID: 17360589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics applications in prion biology and structure.
    Moore RA; Faris R; Priola SA
    Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural localization of prion proteins: physiological and pathological implications.
    Fournier JG; Escaig-Haye F; Grigoriev V
    Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
    Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
    Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of proteomics in understanding prion infection.
    Campisi E; Cardone F; Graziano S; Galeno R; Pocchiari M
    Expert Rev Proteomics; 2012 Dec; 9(6):649-66. PubMed ID: 23256675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.
    Jeffrey M; McGovern G; Makarava N; González L; Kim YS; Rohwer RG; Baskakov IV
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):296-310. PubMed ID: 23578208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale lipidomic profiling identifies novel potential biomarkers for prion diseases and highlights lipid raft-related pathways.
    Kim YC; Lee J; Lee DW; Jeong BH
    Vet Res; 2021 Jul; 52(1):105. PubMed ID: 34289911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.
    Rangel A; Race B; Striebel J; Chesebro B
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):217-30. PubMed ID: 22998478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-associated cerebral amyloid angiopathy is not exacerbated by human phosphorylated tau aggregates in scrapie-infected mice expressing anchorless prion protein.
    Race B; Williams K; Striebel JF; Chesebro B
    Neurobiol Dis; 2020 Oct; 144():105057. PubMed ID: 32829029
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein misfolding and disease.
    Moore RA; Taubner LM; Priola SA
    Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.
    Kobayashi A; Hirata T; Nishikaze T; Ninomiya A; Maki Y; Takada Y; Kitamoto T; Kinoshita T
    J Biol Chem; 2020 May; 295(22):7789-7798. PubMed ID: 32321762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.